Literature DB >> 18473905

The use of proteomics to study infectious diseases.

E O List1, D E Berryman, B Bower, L Sackmann-Sala, E Gosney, J Ding, S Okada, J J Kopchick.   

Abstract

Technology surrounding genomics, or the study of an organism's genome and its gene use, has advanced rapidly resulting in an abundance of readily available genomic data. Although genomics is extremely valuable, proteins are ultimately responsible for controlling most aspects of cellular function. The field of proteomics, or the study of the full array of proteins produced by an organism, has become the premier arena for the identification and characterization of proteins. Yet the task of characterizing a proteomic profile is more complex, in part because many unique proteins can be produced by the same gene product and because proteins have more diverse chemical structures making sequencing and identification more difficult. Proteomic profiles of a particular organism, tissue or cell are influenced by a variety of environmental stimuli, including those brought on by infectious disease. The intent of this review is to highlight applications of proteomics used in the study of pathogenesis, etiology and pathology of infectious disorders. While many infectious agents have been the target of proteomic studies, this review will focus on those infectious diseases which rank among the highest in worldwide mortalities, such as HIV/AIDS, tuberculosis, malaria, measles, and hepatitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18473905     DOI: 10.2174/187152608784139640

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  13 in total

1.  Proteomics technology - a powerful tool for the biomedical scientists.

Authors:  Rahmah Noordin; Nurulhasanah Othman
Journal:  Malays J Med Sci       Date:  2013-03

2.  Identification of three immunologic correlates for HIV type 1 pathogenesis in youth.

Authors:  Wei Song; Yufeng Li; Craig M Wilson; Jianming Tang
Journal:  AIDS Res Hum Retroviruses       Date:  2010-12-13       Impact factor: 2.205

3.  Proteomic analysis of PBMCs: characterization of potential HIV-associated proteins.

Authors:  Lijun Zhang; Xiaofang Jia; Xiaojun Zhang; Jianjun Sun; Xia Peng; Tangkai Qi; Fang Ma; Lin Yin; Yamin Yao; Chao Qiu; Hongzhou Lu
Journal:  Proteome Sci       Date:  2010-03-12       Impact factor: 2.480

4.  Plasmodium falciparum proteome changes in response to doxycycline treatment.

Authors:  Sébastien Briolant; Lionel Almeras; Maya Belghazi; Elodie Boucomont-Chapeaublanc; Nathalie Wurtz; Albin Fontaine; Samuel Granjeaud; Thierry Fusaï; Christophe Rogier; Bruno Pradines
Journal:  Malar J       Date:  2010-05-25       Impact factor: 2.979

5.  Opportunities in proteomics to understand hepatitis C and HIV coinfection.

Authors:  Eric G Meissner; Anthony F Suffredini; Shyamasundaran Kottilil
Journal:  Future Virol       Date:  2012-08       Impact factor: 1.831

Review 6.  Host proteome research in HIV infection.

Authors:  Lijun Zhang; Xiaojun Zhang; Qing Ma; Honghao Zhou
Journal:  Genomics Proteomics Bioinformatics       Date:  2010-03       Impact factor: 7.691

Review 7.  Mass Spectrometry-Based Bacterial Proteomics: Focus on Dermatologic Microbial Pathogens.

Authors:  Youcef Soufi; Boumediene Soufi
Journal:  Front Microbiol       Date:  2016-02-19       Impact factor: 5.640

8.  Proteomic profiling of Serratia marcescens by high-resolution mass spectrometry.

Authors:  Bhavya Somalapura Gangadharappa; Sharath Rajashekarappa; Gajanan Sathe
Journal:  Bioimpacts       Date:  2020-03-26

9.  Large-scale differential proteome analysis in Plasmodium falciparum under drug treatment.

Authors:  Judith Helena Prieto; Sasa Koncarevic; Sung Kyu Park; John Yates; Katja Becker
Journal:  PLoS One       Date:  2008-12-31       Impact factor: 3.240

10.  Unique and differential protein signatures within the mononuclear cells of HIV-1 and HCV mono-infected and co-infected patients.

Authors:  Nawal M Boukli; Vivekananda Shetty; Luis Cubano; Martha Ricaurte; Jordana Coelho-Dos-Reis; Zacharie Nickens; Punit Shah; Andrew H Talal; Ramila Philip; Pooja Jain
Journal:  Clin Proteomics       Date:  2012-09-07       Impact factor: 3.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.